{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:36:32Z","timestamp":1786995392518,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010364","name":"Nederlandse Oogonderzoek Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHS-N-260-2005-00007-C"],"award-info":[{"award-number":["HHS-N-260-2005-00007-C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY000546"],"award-info":[{"award-number":["EY000546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004425","name":"Asian Development Bank","doi-asserted-by":"publisher","award":["NOI-EY-0-2127"],"award-info":[{"award-number":["NOI-EY-0-2127"]}],"id":[{"id":"10.13039\/100004425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004425","name":"Asian Development Bank","doi-asserted-by":"publisher","award":["NO1-EY-5-0007"],"award-info":[{"award-number":["NO1-EY-5-0007"]}],"id":[{"id":"10.13039\/100004425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010376","name":"Stichting Dondersfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000064","name":"National Center for Complementary and Alternative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010326","name":"Stichting A.F. Deutman Oogheelkunde Researchfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000063","name":"Office of Dietary Supplements","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ophtha.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:03:10Z","timestamp":1560297790000},"page":"1541-1548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or \u03b2-Carotene versus Lutein and Zeaxanthin on\u00a0Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease\u00a0Study 2"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-4234","authenticated-orcid":false,"given":"Freekje","family":"van Asten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci E.","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinki","family":"Ratnapriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1975-1141","authenticated-orcid":false,"given":"Anand","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7603-2135","authenticated-orcid":false,"given":"Ruzong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-9802","authenticated-orcid":false,"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ophtha.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A\u00a0randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaophthalmol.2015.0369","article-title":"Genetic testing for age-related macular degeneration: not indicated now","volume":"133","author":"Stone","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2013.07.039","article-title":"CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration","volume":"120","author":"Awh","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ophtha.2014.07.049","article-title":"Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study","volume":"122","author":"Awh","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-308624","article-title":"Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis","volume":"100","author":"Seddon","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ophtha.2008.01.036","article-title":"CFH and LOC387715\/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"E696","DOI":"10.1073\/pnas.1718059115","article-title":"CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation","volume":"115","author":"Vavvas","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ophtha.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.ophtha.2014.05.008","article-title":"No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ophtha.2014.10.012","article-title":"Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?","volume":"122","author":"Chew","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2017.09.008","article-title":"Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with age-related macular degeneration: independent statistical evaluations of data from the Age-Related Eye Disease Study","volume":"125","author":"Assel","year":"2018","journal-title":"Ophthalmology"},{"issue":"19","key":"10.1016\/j.ophtha.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein\u00a0+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.06.004_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archophthalmol.2011.141","article-title":"Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam Study","volume":"129","author":"Ho","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A\u00a0large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.004_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.0006-341X.2000.01016.x","article-title":"Estimation of multivariate frailty models using penalized partial likelihood","volume":"56","author":"Ripatti","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.ophtha.2019.06.004_bib17","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therne","year":"2000"},{"issue":"7","key":"10.1016\/j.ophtha.2019.06.004_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130816","article-title":"CFH Y402H and ARMS2 A69S polymorphisms and oral supplementation with docosahexaenoic acid in neovascular Age-related macular degeneration patients: the NAT2 Study","volume":"10","author":"Merle","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwn358","article-title":"Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort","volume":"169","author":"Wang","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2012.10.020","article-title":"Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy","volume":"120","author":"Reynolds","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ophtha.2017.09.023","article-title":"A\u00a0deep phenotype association study reveals specific phenotype associations with genetic variants in age-related macular degeneration: Age-Related Eye Disease Study 2 (AREDS2) report no. 14","volume":"125","author":"van Asten","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00417-014-2690-7","article-title":"The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration","volume":"252","author":"Dietzel","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018321559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018321559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:52:54Z","timestamp":1777492374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642018321559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0161642018321559"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.004","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or \u03b2-Carotene versus Lutein and Zeaxanthin on\u00a0Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease\u00a0Study 2","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}